Revive Therapeutics Ltd. (RVV)
CSE
0.0250
0.00 (0.00%)
Closed
Aug 24, 2026
Day's Range
0.02500.0250
52 wk Range
0.005000.0800
Financial Statements - RVV - Revive Therapeutics Ltd.
Revenue
0
Net Income
-11.01M▼ 96.0%
EBITDA
-1.65M▲ 48.9%
Free Cash Flow
-767.65K▲ 76.7%
Income Statement
| Period Ending | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -1.64M | -3.28M | -5.52M | -17.83M | -18.59M | -3.68M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -9.36M | -2.37M | -864.50K | -26.70K | -1.54M | -1.65M |
| Pre Tax Income | -11.01M | -5.61M | -6.32M | -17.80M | -20.11M | -5.38M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -11.01M | -5.61M | -6.32M | -17.80M | -20.11M | -5.38M |
| EPS Basic | -0.03 | -0.01 | -0.02 | -0.06 | -0.08 | -0.05 |
| EPS Diluted | -0.03 | -0.01 | -0.02 | -0.06 | -0.08 | -0.05 |
| Basic Shares Outstanding | 419.71M | 380.48M | 339.37M | 319.76M | 267.49M | 106.87M |
| Diluted Shares Outstanding | 419.71M | 380.48M | 339.37M | 319.76M | 267.49M | 106.87M |
| Ebit | -11.01M | -5.59M | -6.27M | -17.74M | -20.03M | -5.29M |
| Ebitda | -1.65M | -3.22M | -5.41M | -17.71M | -18.49M | -4.81M |
| Net Income Continuous Operations | -11.01M | -5.61M | -6.32M | -17.80M | -20.11M | -5.38M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
